Compare Stocks

5 / 10
Try these comparisons:

Stock Comparison

FEMY vs CODA vs BLFS vs XWEL vs HOLO

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
FEMY
Femasys Inc.

Medical - Instruments & Supplies

HealthcareNASDAQ • US
Market Cap$13M
5Y Perf.-94.4%
CODA
Coda Octopus Group, Inc.

Aerospace & Defense

IndustrialsNASDAQ • US
Market Cap$134M
5Y Perf.+30.6%
BLFS
BioLife Solutions, Inc.

Medical - Instruments & Supplies

HealthcareNASDAQ • US
Market Cap$1.13B
5Y Perf.-60.4%
XWEL
XWELL, Inc.

Personal Products & Services

Consumer CyclicalNASDAQ • US
Market Cap$7M
5Y Perf.-96.6%
HOLO
MicroCloud Hologram Inc.

Hardware, Equipment & Parts

TechnologyNASDAQ • CN
Market Cap$3M
5Y Perf.-100.0%

FEMY vs CODA vs BLFS vs XWEL vs HOLO — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
FEMY logoFEMY
CODA logoCODA
BLFS logoBLFS
XWEL logoXWEL
HOLO logoHOLO
IndustryMedical - Instruments & SuppliesAerospace & DefenseMedical - Instruments & SuppliesPersonal Products & ServicesHardware, Equipment & Parts
Market Cap$13M$134M$1.13B$7M$3M
Revenue (TTM)$2M$28M$100M$29M$321M
Net Income (TTM)$-19M$4M$-10M$-17M$295M
Gross Margin62.0%66.3%64.0%22.7%24.2%
Operating Margin-7.7%17.4%-10.9%-32.0%-1.1%
Forward P/E22.5x156.4x
Total Debt$5M$395K$18M$12M$8M
Cash & Equiv.$9M$29M$33M$3M$851M

FEMY vs CODA vs BLFS vs XWEL vs HOLOLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

FEMY
CODA
BLFS
XWEL
HOLO
StockAug 21May 26Return
Femasys Inc. (FEMY)1005.6-94.4%
Coda Octopus Group,… (CODA)100130.6+30.6%
BioLife Solutions, … (BLFS)10039.6-60.4%
XWELL, Inc. (XWEL)1003.4-96.6%
MicroCloud Hologram… (HOLO)1000.0-100.0%

Price return only. Dividends and distributions are not included.

Quick Verdict: FEMY vs CODA vs BLFS vs XWEL vs HOLO

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: HOLO leads in 3 of 7 categories (5-stock set), making it the strongest pick for growth and revenue expansion and profitability and margin quality. Coda Octopus Group, Inc. is the stronger pick specifically for valuation and capital efficiency and recent price momentum and sentiment. XWEL also leads in specific categories worth noting. This set spans 3 sectors — these stocks serve different portfolio roles, not just different price points.
FEMY
Femasys Inc.
The Growth Angle

FEMY lags the leaders in this set but could rank higher in a more targeted comparison.

Best for: healthcare exposure
CODA
Coda Octopus Group, Inc.
The Defensive Pick

CODA is the #2 pick in this set and the best alternative if sleep-well-at-night and defensive is your priority.

  • Lower volatility, beta 1.00, Low D/E 0.7%, current ratio 8.86x
  • Beta 1.00, current ratio 8.86x
  • Better valuation composite
  • +78.9% vs HOLO's -78.7%
Best for: sleep-well-at-night and defensive
BLFS
BioLife Solutions, Inc.
The Long-Run Compounder

BLFS is the clearest fit if your priority is long-term compounding.

  • 12.2% 10Y total return vs CODA's 8.4%
Best for: long-term compounding
XWEL
XWELL, Inc.
The Income Pick

XWEL ranks third and is worth considering specifically for income & stability.

  • Dividend streak 1 yrs, beta 0.88, yield 3.8%
  • Beta 0.88 vs HOLO's 2.19
  • 3.8% yield; 1-year raise streak; the other 4 pay no meaningful dividend
Best for: income & stability
HOLO
MicroCloud Hologram Inc.
The Growth Play

HOLO carries the broadest edge in this set and is the clearest fit for growth exposure.

  • Rev growth 42.6%, EPS growth 94.2%, 3Y rev CAGR -6.8%
  • 42.6% revenue growth vs XWEL's -13.8%
  • 91.9% margin vs FEMY's -8.1%
  • 10.0% ROA vs FEMY's -116.3%, ROIC -27.3% vs -347.4%
Best for: growth exposure
See the full category breakdown
CategoryWinnerWhy
GrowthHOLO logoHOLO42.6% revenue growth vs XWEL's -13.8%
ValueCODA logoCODABetter valuation composite
Quality / MarginsHOLO logoHOLO91.9% margin vs FEMY's -8.1%
Stability / SafetyXWEL logoXWELBeta 0.88 vs HOLO's 2.19
DividendsXWEL logoXWEL3.8% yield; 1-year raise streak; the other 4 pay no meaningful dividend
Momentum (1Y)CODA logoCODA+78.9% vs HOLO's -78.7%
Efficiency (ROA)HOLO logoHOLO10.0% ROA vs FEMY's -116.3%, ROIC -27.3% vs -347.4%

FEMY vs CODA vs BLFS vs XWEL vs HOLO — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

FEMYFemasys Inc.

Segment breakdown not available.

CODACoda Octopus Group, Inc.
FY 2025
Equipment Sales
71.3%$14M
Service
17.3%$4M
Equipment Rentals
7.3%$1M
Software Sales
4.0%$811,912
BLFSBioLife Solutions, Inc.
FY 2024
Product
92.4%$76M
Rental Revenue
7.4%$6M
Service
0.2%$160,000
XWELXWELL, Inc.
FY 2025
Service
89.9%$26M
Product
10.1%$3M
HOLOMicroCloud Hologram Inc.
FY 2024
Services
97.3%$282M
Products
2.7%$8M

FEMY vs CODA vs BLFS vs XWEL vs HOLO — Financial Metrics

Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLCODALAGGINGHOLO

Income & Cash Flow (Last 12 Months)

CODA leads this category, winning 3 of 6 comparable metrics.

HOLO is the larger business by revenue, generating $321M annually — 140.1x FEMY's $2M. HOLO is the more profitable business, keeping 91.9% of every revenue dollar as net income compared to FEMY's -8.1%. On growth, FEMY holds the edge at +39.9% YoY revenue growth, suggesting stronger near-term business momentum.

MetricFEMY logoFEMYFemasys Inc.CODA logoCODACoda Octopus Grou…BLFS logoBLFSBioLife Solutions…XWEL logoXWELXWELL, Inc.HOLO logoHOLOMicroCloud Hologr…
RevenueTrailing 12 months$2M$28M$100M$29M$321M
EBITDAEarnings before interest/tax-$17M$6M-$7M-$8M-$3M
Net IncomeAfter-tax profit-$19M$4M-$10M-$17M$295M
Free Cash FlowCash after capex-$19M$7M$11M-$12M$47M
Gross MarginGross profit ÷ Revenue+62.0%+66.3%+64.0%+22.7%+24.2%
Operating MarginEBIT ÷ Revenue-7.7%+17.4%-10.9%-32.0%-1.1%
Net MarginNet income ÷ Revenue-8.1%+14.8%-10.5%-58.2%+91.9%
FCF MarginFCF ÷ Revenue-8.4%+24.6%+10.6%-40.0%+14.7%
Rev. Growth (YoY)Latest quarter vs prior year+39.9%+28.8%+14.9%-4.2%+24.0%
EPS Growth (YoY)Latest quarter vs prior year+69.9%+3.0%-105.0%+153.4%
CODA leads this category, winning 3 of 6 comparable metrics.

Valuation Metrics

Evenly matched — CODA and HOLO each lead in 2 of 5 comparable metrics.
MetricFEMY logoFEMYFemasys Inc.CODA logoCODACoda Octopus Grou…BLFS logoBLFSBioLife Solutions…XWEL logoXWELXWELL, Inc.HOLO logoHOLOMicroCloud Hologr…
Market CapShares × price$13M$134M$1.1B$7M$3M
Enterprise ValueMkt cap + debt − cash$9M$106M$1.1B$17M-$121M
Trailing P/EPrice ÷ TTM EPS-0.96x32.16x-92.48x-0.25x-0.27x
Forward P/EPrice ÷ next-FY EPS est.22.45x156.43x
PEG RatioP/E ÷ EPS growth rate7.51x
EV / EBITDAEnterprise value multiple17.85x
Price / SalesMarket cap ÷ Revenue5.77x5.05x11.74x0.24x0.06x
Price / BookPrice ÷ Book value/share3.03x2.30x3.02x0.01x
Price / FCFMarket cap ÷ FCF22.20x106.19x
Evenly matched — CODA and HOLO each lead in 2 of 5 comparable metrics.

Profitability & Efficiency

Evenly matched — CODA and HOLO each lead in 4 of 9 comparable metrics.

HOLO delivers a 10.3% return on equity — every $100 of shareholder capital generates $10 in annual profit, vs $-5 for FEMY. HOLO carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to FEMY's 0.80x. On the Piotroski fundamental quality scale (0–9), CODA scores 7/9 vs XWEL's 2/9, reflecting strong financial health.

MetricFEMY logoFEMYFemasys Inc.CODA logoCODACoda Octopus Grou…BLFS logoBLFSBioLife Solutions…XWEL logoXWELXWELL, Inc.HOLO logoHOLOMicroCloud Hologr…
ROE (TTM)Return on equity-5.3%+7.2%-2.9%+10.3%
ROA (TTM)Return on assets-116.3%+6.6%-2.6%-84.7%+10.0%
ROICReturn on invested capital-3.5%+11.2%-2.8%-124.8%-27.3%
ROCEReturn on capital employed-167.9%+8.1%-3.2%-129.5%-16.0%
Piotroski ScoreFundamental quality 0–927623
Debt / EquityFinancial leverage0.80x0.01x0.05x0.00x
Net DebtTotal debt minus cash-$5M-$28M-$15M$10M-$844M
Cash & Equiv.Liquid assets$9M$29M$33M$3M$851M
Total DebtShort + long-term debt$5M$394,932$18M$12M$8M
Interest CoverageEBIT ÷ Interest expense-8.85x-18.62x-128.64x
Evenly matched — CODA and HOLO each lead in 4 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

CODA leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in CODA five years ago would be worth $14,969 today (with dividends reinvested), compared to $0 for HOLO. Over the past 12 months, CODA leads with a +78.9% total return vs HOLO's -78.7%. The 3-year compound annual growth rate (CAGR) favors CODA at 10.4% vs HOLO's -95.1% — a key indicator of consistent wealth creation.

MetricFEMY logoFEMYFemasys Inc.CODA logoCODACoda Octopus Grou…BLFS logoBLFSBioLife Solutions…XWEL logoXWELXWELL, Inc.HOLO logoHOLOMicroCloud Hologr…
YTD ReturnYear-to-date-29.5%+25.1%-3.2%+182.2%-37.9%
1-Year ReturnPast 12 months-60.6%+78.9%+8.3%+54.5%-78.7%
3-Year ReturnCumulative with dividends-40.1%+34.5%+20.7%-75.6%-100.0%
5-Year ReturnCumulative with dividends-96.3%+49.7%-27.0%-95.0%-100.0%
10-Year ReturnCumulative with dividends-96.3%+844.4%+1221.1%-100.0%-100.0%
CAGR (3Y)Annualised 3-year return-15.7%+10.4%+6.5%-37.5%-95.1%
CODA leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

Evenly matched — BLFS and XWEL each lead in 1 of 2 comparable metrics.

XWEL is the less volatile stock with a 0.88 beta — it tends to amplify market swings less than HOLO's 2.19 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. BLFS currently trades 78.1% from its 52-week high vs HOLO's 14.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricFEMY logoFEMYFemasys Inc.CODA logoCODACoda Octopus Grou…BLFS logoBLFSBioLife Solutions…XWEL logoXWELXWELL, Inc.HOLO logoHOLOMicroCloud Hologr…
Beta (5Y)Sensitivity to S&P 5001.10x1.00x1.67x0.88x2.19x
52-Week HighHighest price in past year$1.16$17.28$29.62$2.20$11.82
52-Week LowLowest price in past year$0.31$5.98$17.86$0.26$1.54
% of 52W HighCurrent price vs 52-week peak+38.7%+68.9%+78.1%+57.7%+14.6%
RSI (14)Momentum oscillator 0–10057.348.656.753.443.3
Avg Volume (50D)Average daily shares traded513K256K422K2.3M722K
Evenly matched — BLFS and XWEL each lead in 1 of 2 comparable metrics.

Analyst Outlook

BLFS leads this category, winning 1 of 1 comparable metric.

Analyst consensus: CODA as "Buy", BLFS as "Buy". Consensus price targets imply 42.7% upside for BLFS (target: $33) vs 17.6% for CODA (target: $14). XWEL is the only dividend payer here at 3.78% yield — a key consideration for income-focused portfolios.

MetricFEMY logoFEMYFemasys Inc.CODA logoCODACoda Octopus Grou…BLFS logoBLFSBioLife Solutions…XWEL logoXWELXWELL, Inc.HOLO logoHOLOMicroCloud Hologr…
Analyst RatingConsensus buy/hold/sellBuyBuy
Price TargetConsensus 12-month target$14.00$33.00
# AnalystsCovering analysts117
Dividend YieldAnnual dividend ÷ price+3.8%
Dividend StreakConsecutive years of raises021
Dividend / ShareAnnual DPS$0.05
Buyback YieldShare repurchases ÷ mkt cap0.0%0.0%0.0%+25.4%0.0%
BLFS leads this category, winning 1 of 1 comparable metric.
Key Takeaway

CODA leads in 2 of 6 categories (Income & Cash Flow, Total Returns). BLFS leads in 1 (Analyst Outlook). 3 tied.

Best OverallCoda Octopus Group, Inc. (CODA)Leads 2 of 6 categories
Loading custom metrics...

FEMY vs CODA vs BLFS vs XWEL vs HOLO: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is FEMY or CODA or BLFS or XWEL or HOLO a better buy right now?

For growth investors, MicroCloud Hologram Inc.

(HOLO) is the stronger pick with 42. 6% revenue growth year-over-year, versus -13. 8% for XWELL, Inc. (XWEL). Coda Octopus Group, Inc. (CODA) offers the better valuation at 32. 2x trailing P/E (22. 5x forward), making it the more compelling value choice. Analysts rate Coda Octopus Group, Inc. (CODA) a "Buy" — based on 1 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — FEMY or CODA or BLFS or XWEL or HOLO?

On forward P/E, Coda Octopus Group, Inc.

is actually cheaper at 22. 5x.

03

Which is the better long-term investment — FEMY or CODA or BLFS or XWEL or HOLO?

Over the past 5 years, Coda Octopus Group, Inc.

(CODA) delivered a total return of +49. 7%, compared to -100. 0% for MicroCloud Hologram Inc. (HOLO). Over 10 years, the gap is even starker: BLFS returned +1221% versus HOLO's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — FEMY or CODA or BLFS or XWEL or HOLO?

By beta (market sensitivity over 5 years), XWELL, Inc.

(XWEL) is the lower-risk stock at 0. 88β versus MicroCloud Hologram Inc. 's 2. 19β — meaning HOLO is approximately 149% more volatile than XWEL relative to the S&P 500. On balance sheet safety, MicroCloud Hologram Inc. (HOLO) carries a lower debt/equity ratio of 0% versus 80% for Femasys Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — FEMY or CODA or BLFS or XWEL or HOLO?

By revenue growth (latest reported year), MicroCloud Hologram Inc.

(HOLO) is pulling ahead at 42. 6% versus -13. 8% for XWELL, Inc. (XWEL). On earnings-per-share growth, the picture is similar: MicroCloud Hologram Inc. grew EPS 94. 2% year-over-year, compared to -38. 8% for XWELL, Inc.. Over a 3-year CAGR, FEMY leads at 23. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — FEMY or CODA or BLFS or XWEL or HOLO?

Coda Octopus Group, Inc.

(CODA) is the more profitable company, earning 15. 5% net margin versus -812. 3% for Femasys Inc. — meaning it keeps 15. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CODA leads at 17. 1% versus -767. 0% for FEMY. At the gross margin level — before operating expenses — CODA leads at 66. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is FEMY or CODA or BLFS or XWEL or HOLO more undervalued right now?

On forward earnings alone, Coda Octopus Group, Inc.

(CODA) trades at 22. 5x forward P/E versus 156. 4x for BioLife Solutions, Inc. — 134. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for BLFS: 42. 7% to $33. 00.

08

Which pays a better dividend — FEMY or CODA or BLFS or XWEL or HOLO?

In this comparison, XWEL (3.

8% yield) pays a dividend. FEMY, CODA, BLFS, HOLO do not pay a meaningful dividend and should not be held primarily for income.

09

Is FEMY or CODA or BLFS or XWEL or HOLO better for a retirement portfolio?

For long-horizon retirement investors, Coda Octopus Group, Inc.

(CODA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 00), +844. 4% 10Y return). MicroCloud Hologram Inc. (HOLO) carries a higher beta of 2. 19 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (CODA: +844. 4%, HOLO: -100. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between FEMY and CODA and BLFS and XWEL and HOLO?

These companies operate in different sectors (FEMY (Healthcare) and CODA (Industrials) and BLFS (Healthcare) and XWEL (Consumer Cyclical) and HOLO (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: FEMY is a small-cap high-growth stock; CODA is a small-cap high-growth stock; BLFS is a small-cap high-growth stock; XWEL is a small-cap income-oriented stock; HOLO is a small-cap high-growth stock. XWEL pays a dividend while FEMY, CODA, BLFS, HOLO do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

FEMY

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 19%
  • Gross Margin > 37%
Run This Screen
Stocks Like

CODA

High-Growth Compounder

  • Sector: Industrials
  • Market Cap > $100B
  • Revenue Growth > 14%
  • Net Margin > 8%
Run This Screen
Stocks Like

BLFS

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 7%
  • Gross Margin > 38%
Run This Screen
Stocks Like

XWEL

Income & Dividend Stock

  • Sector: Consumer Cyclical
  • Market Cap > $100B
  • Gross Margin > 13%
  • Dividend Yield > 1.5%
Run This Screen
Stocks Like

HOLO

High-Growth Quality Leader

  • Sector: Technology
  • Market Cap > $100B
  • Revenue Growth > 12%
  • Net Margin > 55%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform FEMY and CODA and BLFS and XWEL and HOLO on the metrics below

Revenue Growth>
%
(FEMY: 39.9% · CODA: 28.8%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.